Home Care News and Research

RSS

Pulse oximeter bias undercounts sleep apnea severity in Black patients

Sleep studies often use a pulse oximeter to determine the severity of sleep apnea. But a new study by investigators from Mass General Brigham reports that pulse oximeters may undercount breathing events in Black patients, potentially leading to inaccurate severity classifications.

4 Nov 2026

New study reveals why colorectal cancer is more aggressive in youth

Dana-Farber Cancer Institute researchers, along with Mass General Brigham researchers from the Gene Lay Institute of Immunology and Inflammation, and the Broad Institute, have uncovered biological clues to why colorectal cancer can behave more aggressively in younger people.

29 Oct 2026

Simple daily habits to protect and strengthen tooth enamel

In a way, teeth are like little nesting dolls. At the center is the pulp, which contains nerves and blood vessels. Dentin surrounds the pulp, and enamel forms the protective outer covering of the tooth's crown.

29 Oct 2026

Routine liver cancer screening extends lives for patients with alcohol-associated cirrhosis

A new study led by investigators from Mass General Brigham found routine liver cancer screening to be cost-effective and life-extending for individuals with alcohol-associated cirrhosis, even when their annual risk of developing liver cancer is less than half the risk level guiding current screening recommendations.

20 Oct 2026

Advanced AI tool estimates biological age and predicts cancer survival from face photos

Researchers are using AI tools to analyze simple facial photographs to determine key indicators of a person's health. Mass General Brigham researchers built FAHR-Face (Foundation Artificial Intelligence for Health Recognition), a large AI foundation model trained on over 40 million face images.

20 Oct 2026

Parents invent home safety fixes for medically complex children

Approximately 1 in 20 U.S. children younger than 18 years of age are medically complex, meaning they have multiorgan system conditions like cerebral palsy and depend on implanted tube-related medical technology.

15 Oct 2026

Multiple immunosuppressive therapies increase infection risks for cancer patients

Retrospective analysis of more than 20,000 patient records identifies opportunities for risk-mitigating approaches in certain patient populations.

24 Sep 2026

Sensory neurons remember past allergens to trigger future allergic reactions

Mass General Brigham researchers found that sensory neurons retain a 'memory' of allergens that may help explain why allergies develop over time.

22 Sep 2026

Stalled gut microbiome development triples risk for type 1 diabetes in children

Type 1 diabetes affects more than 9 million people worldwide, including 1.8 million children and adolescents.

21 Sep 2026

Study illuminates the link between the Epstein-Barr virus and multiple sclerosis

A new study illuminates the connection between the Epstein-Barr virus (EBV) and multiple sclerosis (MS), pointing to a causal role for reactivation of the virus in triggering MS attacks in people with certain genetic risk factors.

16 Sep 2026

Spleen imaging features may reveal coronary artery disease risk

A new study led by investigators from Mass General Brigham reveals that certain features in the spleen hidden within imaging scans may signal a person's risk of coronary artery disease (CAD), suggesting targets for prevention and treatment.

9 Sep 2026

Study identifies education as a key predictor of hip surgery recovery

Level of education is the socio-economic factor most strongly associated with survival rates after acute hip surgery. This is shown in a Linköping University study of 58,000 people.

3 Sep 2026

Newly diagnosed AML patients benefit from less-intensive combination treatment

Investigators from the Mass General Brigham Cancer Institute have found that adults with newly diagnosed acute myeloid leukemia (AML) receiving a less-intensive combination of azacitidine and venetoclax had more than twice as much time before treatment failed, the leukemia returned or worsened, or they died, compared with patients receiving intensive chemotherapy.

2 Sep 2026

KAIST researchers develop flexible micro-LED mask for better skincare

Home beauty devices that let users care for their skin conveniently at home have grown popular recently, but conventional LED masks are limited not only by their rigid structures but also by their point-emitting LEDs, which must be positioned away from the skin to spread light over a broader area.

2 Sep 2026

Antiviral COVID-19 drug shows no benefit for Long COVID

Results from a clinical trial funded by the National Institutes of Health (NIH) and published today in the journal Lancet Infectious Diseases show that the antiviral drug, PAXLOVID, commonly prescribed to treat acute COVID-19, does not have an impact on Long COVID symptoms when compared to placebo.

1 Sep 2026

Brain atrophy on MRI could help predict Alzheimer’s progression

Mass General Brigham Neuroscience Institute researchers have found that a pattern of brain atrophy visible on MRI could help predict how quickly people with early-onset Alzheimer's disease progress from mild cognitive impairment to dementia.

27 Aug 2026

Protecting the thymus may improve lung cancer treatment outcomes

Building on recent discoveries about the adult thymus, Mass General Brigham investigators used artificial intelligence to show that incidental radiation exposure to the thymus may influence outcomes in patients with lung cancer.

25 Aug 2026

Martha's Vineyard Hospital launches study to better understand alpha-gal syndrome

Martha's Vineyard Hospital, a member of Mass General Brigham, has begun recruiting participants for a research study designed to better understand alpha-gal syndrome (AGS), a potentially serious allergic condition associated with lone star tick exposure.

25 Aug 2026

Researchers find alarming rates of CTE in former football players

In a new study from Mass General Brigham, Boston University (BU), and the Concussion & CTE Foundation, researchers found evidence that at least 1-in-4 former NFL players who died between 2016 and 2021 had chronic traumatic encephalopathy (CTE) at the time of their death, a much higher prevalence compared to the general population.

25 Aug 2026

Tick-borne alpha-gal syndrome poses potential risks during blood transfusions

A new multi-institute study led by researchers at Dartmouth Health and Geisel School of Medicine at Dartmouth suggests that alpha-gal syndrome, the tick-borne disease that can result in a chronic allergy to meat and animal byproducts, also may complicate certain patients' ability to safely receive a blood plasma or platelet transfusion.

24 Aug 2026